Therapy for each breast cancer patient needs to be optimized to avoid the delays, side-effects, and costs of ineffective treatments. PET/X combines PET (positron emission tomography) and X-ray mammography to quickly and reliably determine which targeted breast cancer therapies will be effective for each patient. PET/X is also valuable for testing efficacy in newly developed treatments in clinical trials. Our instrument is currently under development for research use only. It is not FDA approved. Please visit our petxllc.com for further information about our company, including available positions (currently seeking experienced software engineer).